Possible Effects on Addiction and Reward Pathways Researchers are actively studying GLP-1 medications for their possible role in reducing: Alcohol cravings Nicotine cravings Compulsive shopping Gambling urges Other dopamine-driven behaviors Some patients report reduced interest in alcohol or other compulsive behaviors while on treatment
The most common contraindications are: Personal or Family history of Thyroid Cancer Personal or family history of Multiple Endocrine Neoplasia Syndrome Type II History of Pancreatitis or pancreatic disease Allergy to GLP-1 Medications If you have any of these contraindications, semaglutide should not be started and Dr
This guide explains exactly what the dual GIP + GLP-1 drug does inside your body-from curbing appetite in week one to dropping A1C and up to 22 % body weight by month 18
Better Health Outcomes: Effective weight loss can reduce the risk of weight-related health issues such as heart disease, hypertension, and type 2 diabetes
Interfere with blood sugar balance, reducing Semaglutides impact
Weight loss outcomes with Wegovy vary from person to person due to factors such as: Consistent use and correct dosing Healthy dietary modifications and exercise habits Starting weight and metabolism Other health conditions and medications Therefore, individual results may vary, and how much weight you lose on Wegovy may be more or less than the average weight loss listed above